Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram-positive, Skin Infections”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Not applicableStudy completedNCT00134342
What this trial is testing

Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations

Who this might be right for
Tuberculosis
University Health Network, Toronto 203
Large-scale testing (Phase 3)Study completedNCT01659437
What this trial is testing

WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8

Who this might be right for
Mycobacterium Ulcerans Infection
University Medical Center Groningen 310
Not applicableStudy completedNCT03683745
What this trial is testing

Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia

Who this might be right for
LeprosyBuruli UlcerYaws+1 more
London School of Hygiene and Tropical Medicine 56,285
Testing effectiveness (Phase 2)Study completedNCT00626795
What this trial is testing

Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)

Who this might be right for
ImpetigoSecondarily Infected Traumatic Lesions
LEO Pharma 773
Not applicableStudy completedNCT00884728
What this trial is testing

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory

Who this might be right for
ScabiesImpetigoPyoderma+1 more
Menzies School of Health Research 2,329
Post-approval studies (Phase 4)Study completedNCT00402402
What this trial is testing

Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease

Who this might be right for
Chronic Liver DiseaseLiver TransplantationTuberculosis
University Health Network, Toronto 300
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Not applicableStudy completedNCT01511341
What this trial is testing

Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases

Who this might be right for
Inflammatory Rheumatism
University of Applied Sciences of Western Switzerland 55
Testing effectiveness (Phase 2)Study completedNCT00514527
What this trial is testing

Patients With Complicated Skin and Skin Structure Infections

Who this might be right for
Staphylococcal Skin InfectionsWounds and InjuriesAbscess+2 more
Targanta Therapeutics Corporation 294
Very early researchWithdrawnNCT03921515
What this trial is testing

Skin Immunity Sample Collection Involving Blisters and Biopsies

Who this might be right for
Hyper-Immunoglobulin E. Syndrome (HEIS)Chronic Granulomatous Disease (CGD)
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)Study completedNCT04485325
What this trial is testing

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Who this might be right for
Rheumatic Arthritis
Dr. Frank Behrens 92
Not applicableStudy completedNCT01153828
What this trial is testing

EU PV for Retapamulin-Prescribing

Who this might be right for
Impetigo
GlaxoSmithKline 1
Not applicableStudy completedNCT06523998
What this trial is testing

A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.

Who this might be right for
SporotrichosisChromomycosisActinomycosis+7 more
Caja Costarricense de Seguro Social 95
Testing effectiveness (Phase 2)Study completedNCT00077675
What this trial is testing

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Who this might be right for
Infections, Gram-positive Bacterial
Cumberland Pharmaceuticals 201
Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24
Post-approval studies (Phase 4)Ended earlyNCT01673061
What this trial is testing

Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage

Who this might be right for
Abscess
Albert Einstein Healthcare Network 21
Testing effectiveness (Phase 2)Study completedNCT01803035
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo

Who this might be right for
Non-bullous Impetigo
Lytix Biopharma AS 210
Not applicableUnknownNCT01306825
What this trial is testing

Clinical Evaluation of Daptomycin Bone Penetration

Who this might be right for
Bone and Joint Infections
University Hospital, Strasbourg, France 15
Post-approval studies (Phase 4)Study completedNCT03278483
What this trial is testing

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)

Who this might be right for
Diabetes MellitusTuberculin (Skin Test) Positive
Instituto Nacional de Salud Publica, Mexico 396
Not applicableEnded earlyNCT06715254
What this trial is testing

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

Who this might be right for
Tuberculosis
Novartis Pharmaceuticals 152
Next Page